Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Greek pharma faces new crunch moment

This article was originally published in Scrip

Executive Summary

A new draft law is looming in Greece which will have far-reaching implications for the pharmaceutical industry. As the various stakeholders haggle over the 2014 medicines budget – and industry warns that a threatened cut of more than 15% to the outpatient drugs bill could spell catastrophe for public health – the health ministry is preparing a draft law on pricing, reimbursement and other issues relevant to the pharma sector that is expected before the end of the month.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts